Intuitive Surgical, Inc.

关键催化剂

• Procedure growth

  Continued da Vinci and Ion procedure growth increases utilization and expands recurring instruments, accessories, and service demand.

• da Vinci 5 adoption

  Growing da Vinci 5 placements can refresh the installed base, deepen customer adoption, and support higher system and recurring revenue over time.

• Installed-base expansion

  Expansion of the da Vinci and Ion installed bases increases the platform available for future procedures, services, and instruments and accessories revenue.

主要风险

• Tariff pressure

  Tariffs are expected to reduce gross margin, and additional measures beyond those assumed in guidance could have a material financial effect.

• Regulatory and competitive risk

  New systems and indications require regulatory clearances, while expanding robotic-surgery competition could pressure placements, pricing, or utilization.

• Lease and capital-spending exposure

  A large share of systems placed under operating leases increases exposure to customer utilization and can delay revenue recognition relative to outright sales.

For the quarter ended March 31, 2026, Intuitive reported strong revenue and earnings growth driven by higher procedure volumes, system placements, and installed bases across da Vinci and Ion, while its outlook incorporated a material tariff impact on gross margin.

估值解读

• A durable premium depends on procedure growth converting into recurring revenue across a larger da Vinci and Ion installed base.
• Tariff pressure, regulatory execution, and emerging competition warrant a discount if they weaken margins or slow platform adoption.